Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Change in Cash (2016 - 2025)

Biomerica's Change in Cash history spans 16 years, with the latest figure at -$510000.0 for Q4 2025.

  • For Q4 2025, Change in Cash fell 13.84% year-over-year to -$510000.0; the TTM value through Nov 2025 reached $172000.0, up 103.61%, while the annual FY2025 figure was -$1.8 million, 68.1% up from the prior year.
  • Change in Cash for Q4 2025 was -$510000.0 at Biomerica, down from $654000.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $6.4 million in Q2 2023 and bottomed at -$4.3 million in Q2 2022.
  • The 5-year median for Change in Cash is -$584000.0 (2025), against an average of -$156923.8.
  • The largest annual shift saw Change in Cash soared 823.37% in 2022 before it crashed 1195.57% in 2023.
  • A 5-year view of Change in Cash shows it stood at $2.2 million in 2021, then tumbled by 145.77% to -$1.0 million in 2022, then rose by 15.28% to -$854000.0 in 2023, then soared by 47.54% to -$448000.0 in 2024, then fell by 13.84% to -$510000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Change in Cash are -$510000.0 (Q4 2025), $654000.0 (Q3 2025), and -$658000.0 (Q2 2025).